Cargando…
Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study
INTRODUCTION: Lifelong anticoagulation is the cornerstone of the chronic thromboembolic pulmonary hypertension (CTEPH) treatment regardless of the additional pulmonary endarterectomy, balloon pulmonary angioplasty, or medical treatment alone. Aim of this study was to evaluate the rate of oral antico...
Autores principales: | Sena, Sert, Bulent, Mutlu, Derya, Kocakaya, Deniz, Kaptan, Halil, Ataş, Okan, Erdogan, Bedrettin, Yıldızeli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031796/ https://www.ncbi.nlm.nih.gov/pubmed/32128155 http://dx.doi.org/10.1177/2045894019873545 |
Ejemplares similares
-
Are Guideline-recommended Risk Classification Schemes in Pulmonary Hypertension Adequately Robust to Guide the Real-world Setting?
por: Akaslan, Dursun, et al.
Publicado: (2023) -
Pulmonary Endarterectomy in Patients with Antiphospholipid Syndrome-Associated Chronic Thromboembolic Pulmonary Hypertension
por: Taş, Serpil, et al.
Publicado: (2022) -
Change in pulmonary arterial compliance and pulmonary pulsatile stress after balloon pulmonary angioplasty
por: Akaslan, Dursun, et al.
Publicado: (2021) -
Determinants of Severe Nocturnal Hypoxemia in Adults with Chronic Thromboembolic Pulmonary Hypertension and Sleep-Related Breathing Disorders
por: Çınar, Caner, et al.
Publicado: (2023) -
Pulmonary hypertension in patients with sarcoidosis: A single-center experience
por: Kaptan Özen, Deniz, et al.
Publicado: (2020)